As the authors of the title paper [1], it is with great regret that we inform the readership of Metabolites that we have asked the journal’s publisher, MDPI, to retract the paper from the scientific literature. Due to human error, we included contents similar to article [2], which has already been published by Pirola et al. We apologize to the readership of Metabolites and to the authors of [2] for any inconvenience caused.
MDPI is a member of the Committee on Publication Ethics (COPE) and takes the responsibility to enforce strict ethical policies and standards very seriously. To ensure the integrity of the publication record, [1] is retracted and shall be marked accordingly.
References
- 1.Carulli L., Zanca G., Schepis F., Villa E. The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD) Metabolites. 2019;9:25. doi: 10.3390/metabo9020025. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Pirola C.J., Sookoian S. Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity. World J. Gastroenterol. 2018;24:1601–1615. doi: 10.3748/wjg.v24.i15.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]